http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 23 Dec 2024 17:15:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIONOMICS+LIMITEDFI++++++For%3A+Dec+23/24140104.html si-local-file:///var/storage/secattach/20241223/24140104.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIONOMICS+LIMITEDFI++++++For%3A+Dec+23/24140104.html Mon, 23 Dec 2024 17:15:00 -0500 BNOX O.00730679 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIONOMICS+LIMITEDFI++++++For%3A+Dec+23/24140104.html si-local-file:///var/storage/secattach/20241223/24140104.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIONOMICS+LIMITEDFI++++++For%3A+Dec+23/24140104.html Mon, 23 Dec 2024 17:15:00 -0500 BNOX O.00730679 http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++BIONOMICS+LIMITEDFI+++++++++++++++++/24140016.html si-local-file:///var/storage/secattach/20241223/24140016.html http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++BIONOMICS+LIMITEDFI+++++++++++++++++/24140016.html Mon, 23 Dec 2024 17:04:00 -0500 BNOX O.00730679 http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++BIONOMICS+LIMITEDFI+++++++++++++++++/24140016.html si-local-file:///var/storage/secattach/20241223/24140016.html http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++BIONOMICS+LIMITEDFI+++++++++++++++++/24140016.html Mon, 23 Dec 2024 17:04:00 -0500 BNOX O.00730679 http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++BIONOMICS+LIMITEDFI+++++++++++++++++/24139991.html si-local-file:///var/storage/secattach/20241223/24139991.html http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++BIONOMICS+LIMITEDFI+++++++++++++++++/24139991.html Mon, 23 Dec 2024 17:02:00 -0500 BNOX O.00730679 http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++BIONOMICS+LIMITEDFI+++++++++++++++++/24139991.html si-local-file:///var/storage/secattach/20241223/24139991.html http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++BIONOMICS+LIMITEDFI+++++++++++++++++/24139991.html Mon, 23 Dec 2024 17:02:00 -0500 BNOX O.00730679 http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++BIONOMICS+LIMITEDFI+++++++++++++++++/24139897.html si-local-file:///var/storage/secattach/20241223/24139897.html http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++BIONOMICS+LIMITEDFI+++++++++++++++++/24139897.html Mon, 23 Dec 2024 16:56:00 -0500 BNOX O.00730679 http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++BIONOMICS+LIMITEDFI+++++++++++++++++/24139897.html si-local-file:///var/storage/secattach/20241223/24139897.html http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++BIONOMICS+LIMITEDFI+++++++++++++++++/24139897.html Mon, 23 Dec 2024 16:56:00 -0500 BNOX O.00730679 http://www.streetinsider.com/Press+Releases/Neuphoria+Completes+Re-domiciliation+and+Successor+Listing+on+Nasdaq/24139819.html <p align="left">BURLINGTON, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“<strong>Neuphoria</strong>” or the “<strong>Company</strong>”) is pleased to announce that its previously announced scheme of arrangement in relation to Bionomics Limited’s proposed re-domiciliation from Australia to the United States, under which Neuphoria will become the ultimate parent company of Bionomics Limited, has been implemented today, December 23, 2024 New York time (December 24, 2024 Sydney time).</p> <p>The shares of common stock of Neuphoria (“<strong>Neuphoria Shares</strong>”) issued today in connection with the re-domiciliation are expected to commence trading on The Nasdaq Stock Market LLC under http://www.streetinsider.com/Press+Releases/Neuphoria+Completes+Re-domiciliation+and+Successor+Listing+on+Nasdaq/24139819.html Mon, 23 Dec 2024 16:49:00 -0500 BNOX NEUP O.00730679 http://www.streetinsider.com/Press+Releases/Neuphoria+Completes+Re-domiciliation+and+Successor+Listing+on+Nasdaq/24139819.html <p align="left">BURLINGTON, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“<strong>Neuphoria</strong>” or the “<strong>Company</strong>”) is pleased to announce that its previously announced scheme of arrangement in relation to Bionomics Limited’s proposed re-domiciliation from Australia to the United States, under which Neuphoria will become the ultimate parent company of Bionomics Limited, has been implemented today, December 23, 2024 New York time (December 24, 2024 Sydney time).</p> <p>The shares of common stock of Neuphoria (“<strong>Neuphoria Shares</strong>”) issued today in connection with the re-domiciliation are expected to commence trading on The Nasdaq Stock Market LLC under http://www.streetinsider.com/Press+Releases/Neuphoria+Completes+Re-domiciliation+and+Successor+Listing+on+Nasdaq/24139819.html Mon, 23 Dec 2024 16:49:00 -0500 BNOX NEUP O.00730679 http://www.streetinsider.com/Press+Releases/Neuphoria+Completes+Re-domiciliation+and+Successor+Listing+on+Nasdaq/24139819.html <p align="left">BURLINGTON, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“<strong>Neuphoria</strong>” or the “<strong>Company</strong>”) is pleased to announce that its previously announced scheme of arrangement in relation to Bionomics Limited’s proposed re-domiciliation from Australia to the United States, under which Neuphoria will become the ultimate parent company of Bionomics Limited, has been implemented today, December 23, 2024 New York time (December 24, 2024 Sydney time).</p> <p>The shares of common stock of Neuphoria (“<strong>Neuphoria Shares</strong>”) issued today in connection with the re-domiciliation are expected to commence trading on The Nasdaq Stock Market LLC under http://www.streetinsider.com/Press+Releases/Neuphoria+Completes+Re-domiciliation+and+Successor+Listing+on+Nasdaq/24139819.html Mon, 23 Dec 2024 16:49:00 -0500 BNOX NEUP O.00730679 http://www.streetinsider.com/Globe+Newswire/Neuphoria+Completes+Re-domiciliation+and+Successor+Listing+on+Nasdaq/24139819.html <p align="left">BURLINGTON, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“<strong>Neuphoria</strong>” or the “<strong>Company</strong>”) is pleased to announce that its previously announced scheme of arrangement in relation to Bionomics Limited’s proposed re-domiciliation from Australia to the United States, under which Neuphoria will become the ultimate parent company of Bionomics Limited, has been implemented today, December 23, 2024 New York time (December 24, 2024 Sydney time).</p> <p>The shares of common stock of Neuphoria (“<strong>Neuphoria Shares</strong>”) issued today in connection with the re-domiciliation are expected to commence trading on The Nasdaq Stock Market LLC under http://www.streetinsider.com/Globe+Newswire/Neuphoria+Completes+Re-domiciliation+and+Successor+Listing+on+Nasdaq/24139819.html Mon, 23 Dec 2024 16:49:00 -0500 BNOX NEUP O.00730679 http://www.streetinsider.com/Globe+Newswire/Neuphoria+Completes+Re-domiciliation+and+Successor+Listing+on+Nasdaq/24139819.html <p align="left">BURLINGTON, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“<strong>Neuphoria</strong>” or the “<strong>Company</strong>”) is pleased to announce that its previously announced scheme of arrangement in relation to Bionomics Limited’s proposed re-domiciliation from Australia to the United States, under which Neuphoria will become the ultimate parent company of Bionomics Limited, has been implemented today, December 23, 2024 New York time (December 24, 2024 Sydney time).</p> <p>The shares of common stock of Neuphoria (“<strong>Neuphoria Shares</strong>”) issued today in connection with the re-domiciliation are expected to commence trading on The Nasdaq Stock Market LLC under http://www.streetinsider.com/Globe+Newswire/Neuphoria+Completes+Re-domiciliation+and+Successor+Listing+on+Nasdaq/24139819.html Mon, 23 Dec 2024 16:49:00 -0500 BNOX NEUP O.00730679 http://www.streetinsider.com/Globe+Newswire/Neuphoria+Completes+Re-domiciliation+and+Successor+Listing+on+Nasdaq/24139819.html <p align="left">BURLINGTON, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“<strong>Neuphoria</strong>” or the “<strong>Company</strong>”) is pleased to announce that its previously announced scheme of arrangement in relation to Bionomics Limited’s proposed re-domiciliation from Australia to the United States, under which Neuphoria will become the ultimate parent company of Bionomics Limited, has been implemented today, December 23, 2024 New York time (December 24, 2024 Sydney time).</p> <p>The shares of common stock of Neuphoria (“<strong>Neuphoria Shares</strong>”) issued today in connection with the re-domiciliation are expected to commence trading on The Nasdaq Stock Market LLC under http://www.streetinsider.com/Globe+Newswire/Neuphoria+Completes+Re-domiciliation+and+Successor+Listing+on+Nasdaq/24139819.html Mon, 23 Dec 2024 16:49:00 -0500 BNOX NEUP O.00730679 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIONOMICS+LIMITEDFI++++++For%3A+Dec+16/24110866.html si-local-file:///var/storage/secattach/20241216/24110866.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIONOMICS+LIMITEDFI++++++For%3A+Dec+16/24110866.html Mon, 16 Dec 2024 16:47:00 -0500 BNOX O.00730679 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIONOMICS+LIMITEDFI++++++For%3A+Dec+16/24110866.html si-local-file:///var/storage/secattach/20241216/24110866.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIONOMICS+LIMITEDFI++++++For%3A+Dec+16/24110866.html Mon, 16 Dec 2024 16:47:00 -0500 BNOX O.00730679 http://www.streetinsider.com/Corporate+News/Bionomics+%28BNOX%29+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110151.html <p>Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) is pleased to announce that the Supreme Court of New South Wales, Australia (“Court”) has today made orders approving the scheme of arrangement in relation to the Company’s proposed re-domiciliation from Australia to the United States (“Scheme”), under which Neuphoria Therapeutics Inc., a Delaware corporation (“Neuphoria”), will become the ultimate parent company of Bionomics Limited following the implementation of the Scheme.</p><p>A copy of the Court’s orders with respect to the Scheme was lodged with the Australian Securities & Investments Commission following the Court hearing, at which time the Scheme became legally effective. Bionomics’ http://www.streetinsider.com/Corporate+News/Bionomics+%28BNOX%29+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110151.html Mon, 16 Dec 2024 16:08:28 -0500 BNOX http://www.streetinsider.com/Press+Releases/Bionomics+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110039.html <p align="left">ADELAIDE, Australia, and CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) is pleased to announce that the Supreme Court of New South Wales, Australia (“Court”) has today made orders approving the scheme of arrangement in relation to the Company’s proposed re-domiciliation from Australia to the United States (“Scheme”), under which Neuphoria Therapeutics Inc., a Delaware corporation (“Neuphoria”), will become the ultimate parent company of Bionomics Limited following the implementation of the Scheme.</p> <p>A copy of the Court’s orders with respect to the Scheme was lodged with the Australian Securities &amp; http://www.streetinsider.com/Press+Releases/Bionomics+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110039.html Mon, 16 Dec 2024 16:05:00 -0500 A.13676244 A.30313924 BNOX O.00730679 O.16637442 O.20313690 http://www.streetinsider.com/Press+Releases/Bionomics+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110039.html <p align="left">ADELAIDE, Australia, and CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) is pleased to announce that the Supreme Court of New South Wales, Australia (“Court”) has today made orders approving the scheme of arrangement in relation to the Company’s proposed re-domiciliation from Australia to the United States (“Scheme”), under which Neuphoria Therapeutics Inc., a Delaware corporation (“Neuphoria”), will become the ultimate parent company of Bionomics Limited following the implementation of the Scheme.</p> <p>A copy of the Court’s orders with respect to the Scheme was lodged with the Australian Securities &amp; http://www.streetinsider.com/Press+Releases/Bionomics+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110039.html Mon, 16 Dec 2024 16:05:00 -0500 A.13676244 A.30313924 BNOX O.00730679 O.16637442 O.20313690 http://www.streetinsider.com/Press+Releases/Bionomics+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110039.html <p align="left">ADELAIDE, Australia, and CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) is pleased to announce that the Supreme Court of New South Wales, Australia (“Court”) has today made orders approving the scheme of arrangement in relation to the Company’s proposed re-domiciliation from Australia to the United States (“Scheme”), under which Neuphoria Therapeutics Inc., a Delaware corporation (“Neuphoria”), will become the ultimate parent company of Bionomics Limited following the implementation of the Scheme.</p> <p>A copy of the Court’s orders with respect to the Scheme was lodged with the Australian Securities &amp; http://www.streetinsider.com/Press+Releases/Bionomics+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110039.html Mon, 16 Dec 2024 16:05:00 -0500 A.13676244 A.30313924 BNOX O.00730679 O.16637442 O.20313690 http://www.streetinsider.com/Press+Releases/Bionomics+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110039.html <p align="left">ADELAIDE, Australia, and CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) is pleased to announce that the Supreme Court of New South Wales, Australia (“Court”) has today made orders approving the scheme of arrangement in relation to the Company’s proposed re-domiciliation from Australia to the United States (“Scheme”), under which Neuphoria Therapeutics Inc., a Delaware corporation (“Neuphoria”), will become the ultimate parent company of Bionomics Limited following the implementation of the Scheme.</p> <p>A copy of the Court’s orders with respect to the Scheme was lodged with the Australian Securities &amp; http://www.streetinsider.com/Press+Releases/Bionomics+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110039.html Mon, 16 Dec 2024 16:05:00 -0500 A.13676244 A.30313924 BNOX O.00730679 O.16637442 O.20313690 http://www.streetinsider.com/Press+Releases/Bionomics+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110039.html <p align="left">ADELAIDE, Australia, and CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) is pleased to announce that the Supreme Court of New South Wales, Australia (“Court”) has today made orders approving the scheme of arrangement in relation to the Company’s proposed re-domiciliation from Australia to the United States (“Scheme”), under which Neuphoria Therapeutics Inc., a Delaware corporation (“Neuphoria”), will become the ultimate parent company of Bionomics Limited following the implementation of the Scheme.</p> <p>A copy of the Court’s orders with respect to the Scheme was lodged with the Australian Securities &amp; http://www.streetinsider.com/Press+Releases/Bionomics+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110039.html Mon, 16 Dec 2024 16:05:00 -0500 A.13676244 A.30313924 BNOX O.00730679 O.16637442 O.20313690 http://www.streetinsider.com/Press+Releases/Bionomics+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110039.html <p align="left">ADELAIDE, Australia, and CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) is pleased to announce that the Supreme Court of New South Wales, Australia (“Court”) has today made orders approving the scheme of arrangement in relation to the Company’s proposed re-domiciliation from Australia to the United States (“Scheme”), under which Neuphoria Therapeutics Inc., a Delaware corporation (“Neuphoria”), will become the ultimate parent company of Bionomics Limited following the implementation of the Scheme.</p> <p>A copy of the Court’s orders with respect to the Scheme was lodged with the Australian Securities &amp; http://www.streetinsider.com/Press+Releases/Bionomics+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110039.html Mon, 16 Dec 2024 16:05:00 -0500 A.13676244 A.30313924 BNOX O.00730679 O.16637442 O.20313690 http://www.streetinsider.com/Globe+Newswire/Bionomics+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110039.html <p align="left">ADELAIDE, Australia, and CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) is pleased to announce that the Supreme Court of New South Wales, Australia (“Court”) has today made orders approving the scheme of arrangement in relation to the Company’s proposed re-domiciliation from Australia to the United States (“Scheme”), under which Neuphoria Therapeutics Inc., a Delaware corporation (“Neuphoria”), will become the ultimate parent company of Bionomics Limited following the implementation of the Scheme.</p> <p>A copy of the Court’s orders with respect to the Scheme was lodged with the Australian Securities &amp; http://www.streetinsider.com/Globe+Newswire/Bionomics+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110039.html Mon, 16 Dec 2024 16:05:00 -0500 A.13676244 A.30313924 BNOX O.00730679 O.16637442 O.20313690 http://www.streetinsider.com/Globe+Newswire/Bionomics+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110039.html <p align="left">ADELAIDE, Australia, and CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) is pleased to announce that the Supreme Court of New South Wales, Australia (“Court”) has today made orders approving the scheme of arrangement in relation to the Company’s proposed re-domiciliation from Australia to the United States (“Scheme”), under which Neuphoria Therapeutics Inc., a Delaware corporation (“Neuphoria”), will become the ultimate parent company of Bionomics Limited following the implementation of the Scheme.</p> <p>A copy of the Court’s orders with respect to the Scheme was lodged with the Australian Securities &amp; http://www.streetinsider.com/Globe+Newswire/Bionomics+Announces+Supreme+Court+of+New+South+Wales+Approves+Bionomics%E2%80%99+Re-Domiciliation/24110039.html Mon, 16 Dec 2024 16:05:00 -0500 A.13676244 A.30313924 BNOX O.00730679 O.16637442 O.20313690